A Biomarker That May Predict NSCLC Response to Immunotherapy DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 43(10):38, May 20, 2021. Favorites PDF Get Content & Permissions Free
Overcoming Challenges to Broaden Adoptive T-Cell Therapy in Lung Cancer Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 43(9):19-20, May 5, 2021. Favorites PDF Get Content & Permissions Free
USPSTF Updates Lung Cancer Screening Guidelines DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 43(9):1,11, May 5, 2021. Favorites PDF Get Content & Permissions Free
A Metabolic Pathway Driving Growth of Aggressive Lung Cancers Gallagher, Amy Gallagher, Amy Less Oncology Times. 43(8):29, April 20, 2021. Favorites PDF Get Content & Permissions Free
Antimalarial Atovaquone May Improve Lung Cancer Treatment Outcomes Balakrishnan, Vijay Shankar Balakrishnan, Vijay Shankar Less Oncology Times. 43(8):27, April 20, 2021. Favorites PDF Get Content & Permissions Free
Lung Cancer Patients at Risk of Hyperprogressive Disease Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(8):23,25, April 20, 2021. Favorites PDF Get Content & Permissions Free
Deep Learning Models Tackle Lung Cancer Survival Period Prediction Holt, Chuck Holt, Chuck Less Oncology Times. 43(8):21, April 20, 2021. Favorites PDF Get Content & Permissions Free
The Impact of the COVID-19 Pandemic on Lung Cancer Screening Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 43(8):12, April 20, 2021. Favorites PDF Get Content & Permissions Free
3 QUESTIONS ON... When Enthusiasm for New Cancer Drugs Is Premature: With Bishal Gyawali, MD, PhD, of Queen's University Cancer Research Institute, Kingston, Ontario, Canada DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 43(7):42, April 5, 2021. Favorites PDF Get Content & Permissions Free
Capmatinib (Tabrecta™) Sproat, Michelle; Mann, Janelle E. Sproat, Michelle; Mann, Janelle E. Less Oncology Times. 43(6):14,41, March 20, 2021. Favorites PDF Get Content & Permissions Free
Predicting Recurrence in Patients With Completely Resected Lung Cancer Nalley, Catlin Nalley, Catlin Less Oncology Times. 43(5):17, March 5, 2021. Favorites PDF Get Content & Permissions Free
Artificial Intelligence Facilitates Accurate NSCLC Treatment Decisions Samson, Kurt Samson, Kurt Less Oncology Times. 43(4):34, February 20, 2021. Favorites PDF Get Content & Permissions Free
Tackling Muscle Wasting & Malnutrition Among Lung Cancer Patients Nalley, Catlin Nalley, Catlin Less Oncology Times. 43(3):16-17, February 5, 2021. Favorites PDF Get Content & Permissions Free
Cemiplimab Monotherapy as First-Line Treatment for Certain NSCLC Patients Nalley, Catlin Nalley, Catlin Less Oncology Times. 43(1):34, January 5, 2021. Favorites PDF Get Content & Permissions Free
Predicting the Risk of Severe Side Effects of Cancer Treatment Less Oncology Times. 42(24):71, December 20, 2020. Favorites PDF Get Content & Permissions Free
FDA Approval of Immunotherapy Drugs Brings Hope to Mesothelioma Patients Conick, Hal Conick, Hal Less Oncology Times. 42(24):1,5, December 20, 2020. Favorites PDF Get Content & Permissions Free
Ensartinib as Treatment for ALK-Rearranged NSCLC Wong, Selina K.; Cass, Amanda S.; Horn, Leora Wong, Selina K.; Cass, Amanda S.; Horn, Leora Less Oncology Times. 42(20):1-8, October 20, 2020. Favorites PDF Get Content & Permissions Free
Ensartinib as Treatment for ALK-Rearranged NSCLC Wong, Selina K.; Cass, Amanda S.; Horn, Leora Wong, Selina K.; Cass, Amanda S.; Horn, Leora Less Oncology Times. 42(20):1-8, October 20, 2020. Favorites PDF Get Content & Permissions Free
RET Inhibitor Selpercatinib Achieves Durable Responses in Lung Cancer Less Oncology Times. 42(18):40, September 20, 2020. Favorites PDF Get Content & Permissions Free
Year In Review: 2020 Mesothelioma Treatments & Clinical Trials Less Oncology Times. 42(18):25, September 20, 2020. Favorites PDF Get Content & Permissions Free
Precision Therapy in Lung Cancer Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(18):21, September 20, 2020. Favorites PDF Get Content & Permissions Free
Precision Therapy in Lung Cancer Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(18):21, September 20, 2020. Favorites PDF Get Content & Permissions Free
Lurbinectedin (Zepzelca™) Mann, Janelle E. Mann, Janelle E. Less Oncology Times. 42(18):18, September 20, 2020. Favorites PDF Get Content & Permissions Free
New Treatments Spur Sharp Reduction in Lung Cancer Mortality Rate Less Oncology Times. 42(17):28, September 5, 2020. Favorites PDF Get Content & Permissions Free
Intensive Care for Patients With Lung Cancer & COVID-19 Infection Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 42(15):1,10, August 5, 2020. Favorites PDF Get Content & Permissions Free
Durvalumab Gets FDA Green Light for Treatment of Extensive-Stage SCLC May, Brandon May, Brandon Less Oncology Times. 42(12):38, June 20, 2020. Favorites PDF Get Content & Permissions Free
Clinical Activity of RAF/MEK + FAK Combo in KRAS-Mutant Tumors Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(12):32,37, June 20, 2020. Favorites PDF Get Content & Permissions Free
Incidence of Tobacco & Vaping in Low-Income, Ethnically Dense Communities Froelich, Warren Froelich, Warren Less Oncology Times. 42(11):32, June 5, 2020. Favorites PDF Get Content & Permissions Free
Leukemia Drugs Hold Promise for Treatment-Resistant Lung Cancer Less Oncology Times. 42(6):27, March 20, 2020. Favorites PDF Get Content & Permissions Free
Genomic Analyses Predict Response to Immunotherapy in Lung Cancer Less Oncology Times. 42(6):20, March 20, 2020. Favorites PDF Get Content & Permissions Free
Reducing Malnutrition Among Patients With Lung Cancer Barry Thias, Bridget Barry Thias, Bridget Less Oncology Times. 42(5):27, March 5, 2020. Favorites PDF Get Content & Permissions Free
Global Green Light for CT Lung Cancer Screening Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 42(5):20-21, March 5, 2020. Favorites PDF Get Content & Permissions Free
Surgeon General Urges Clinicians to Do More to Curb Smoking Eastman, Peggy Eastman, Peggy Less Oncology Times. 42(4):1,6, February 20, 2020. Favorites PDF Get Content & Permissions Free
Nivolumab + Ipilimumab in Patients with Advanced NSCLC Less Oncology Times. 42(2):28, January 20, 2020. Favorites PDF Get Content & Permissions Free
Pembrolizumab as First-Line Treatment in Non-Squamous NSCLC Less Oncology Times. 42(2):27,30, January 20, 2020. Favorites PDF Get Content & Permissions Free
Linking Immune Cell to Failure of Checkpoint Inhibitors in Lung Cancer Less Oncology Times. 42(2):20, January 20, 2020. Favorites PDF Get Content & Permissions Free
‘It's a Big Deal’: Surgeon Group Studying Thoracic Disease Is Growing Conick, Hal Conick, Hal Less Oncology Times. 42(1):22, January 5, 2020. Favorites PDF Get Content & Permissions Free
SBRT Heightens Immune Response in Some Metastatic NSCLC Patients Samson, Kurt Samson, Kurt Less Oncology Times. 41(23):36, December 5, 2019. Favorites PDF Get Content & Permissions Free
CASPIAN Trial Highlights Extensive Stage Small Cell Lung Cancer Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(22):38, November 20, 2019. Favorites PDF Get Content & Permissions Free
Pembrolizumab Plus Chemo for Advanced Non-Small Cell Lung Cancer Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(22):37, November 20, 2019. Favorites PDF Get Content & Permissions Free
Vaping: Regulation Is Required to Deter Potential Oncological Outcomes Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 41(22):11-14, November 20, 2019. Favorites PDF Get Content & Permissions Free
Trial of Irreversible KRASG12C Inhibitor AMG 510 Reveals Clinical Activity Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(21):33, November 5, 2019. Favorites PDF Get Content & Permissions Free
The Benefit of Using Immunotherapy With Ablation in NSCLC May, Brandon May, Brandon Less Oncology Times. 41(19):15, October 5, 2019. Favorites PDF Get Content & Permissions Free
Advances in Next-Generation Sequencing for Non-Small Cell Lung Cancer Vidaurri, Vincent Vidaurri, Vincent Less Oncology Times. 41(17):19,27, September 5, 2019. Favorites PDF Get Content & Permissions Free
Pembrolizumab Provides Long-Term Survival in Advanced Lung Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(16):33, August 20, 2019. Favorites PDF Get Content & Permissions Free
Traditional & Complementary Treatments for Mesothelioma Patients Less Oncology Times. 41(16):24, August 20, 2019. Favorites PDF Get Content & Permissions Free
Lung Cancer Responses With RET-Fusion Targeted Therapy Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(15):34, August 5, 2019. Favorites PDF Get Content & Permissions Free
Advanced NSCLC: EGFR Exon 20 Targeting Success Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(15):29, August 5, 2019. Favorites PDF Get Content & Permissions Free
New Digital Tools Could Improve Treatment for Lung Cancer Patients Hirsch, Fred R. Hirsch, Fred R. Less Oncology Times. 41(13):26,29, July 5, 2019. Favorites PDF Get Content & Permissions Free
Predictive Models Could Individualize Therapy for Small Cell Lung Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(11):30, June 5, 2019. Favorites PDF Get Content & Permissions Free
Gene Profiling in Recurrent Small Cell Lung Cancer Hepp, Rebecca Hepp, Rebecca Less Oncology Times. 41(11):28-29, June 5, 2019. Favorites PDF Get Content & Permissions Free
Ways to Improve Care Access for Underserved Lung Cancer Patients May, Brandon May, Brandon Less Oncology Times. 41(11):15, June 5, 2019. Favorites PDF Get Content & Permissions Free
MET Plus EGFR Inhibitors in Resistant Lung Cancer Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(10):35, May 20, 2019. Favorites PDF Get Content & Permissions Free
Pembrolizumab Shows Promising Activity in Small Cell Lung Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(10):32, May 20, 2019. Favorites PDF Get Content & Permissions Free
Novel Approach Shows Promise for Treatment of SCLC Brophy Marcus, Mary Brophy Marcus, Mary Less Oncology Times. 41(10):24, May 20, 2019. Favorites PDF Get Content & Permissions Free
Liquid Biopsy Identifies Lung Cancer Biomarkers Faster Than Tissue Tests Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(8):33, April 20, 2019. Favorites PDF Get Content & Permissions Free
Higher Doses of Second-Line Nivolumab Safe & Effective for Advanced NSCLC Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(8):30, April 20, 2019. Favorites PDF Get Content & Permissions Free
Prophylactic Cranial Irradiation Use Down Sharply for Extensive-Stage SCLC Samson, Kurt Samson, Kurt Less Oncology Times. 41(8):27, April 20, 2019. Favorites PDF Get Content & Permissions Free
Web-Based Guideline Tool Increases NSCLC Patients in Decisions Samson, Kurt Samson, Kurt Less Oncology Times. 41(8):26, April 20, 2019. Favorites PDF Get Content & Permissions Free
Oligometastatic NSCLC: Consolidation Therapy May Provide Survival Edge Samson, Kurt Samson, Kurt Less Oncology Times. 41(8):25,37, April 20, 2019. Favorites PDF Get Content & Permissions Free
ZEB1 Throttles Therapeutic Target, Protects KRAS-Mutant Lung Cancer Less Oncology Times. 41(7):32-34, April 5, 2019. Favorites PDF Get Content & Permissions Free
Immunotherapy Advances in Non-Small Cell Lung Cancer Johnson, Melissa; Zimmerman, Lisa J. Johnson, Melissa; Zimmerman, Lisa J. Less Oncology Times. 41(7):12,13,35, April 5, 2019. Favorites PDF Get Content & Permissions Free
Lorlatinib (Lorbrena®) Mann, Janelle E. Mann, Janelle E. Less Oncology Times. 41(6):5, March 20, 2019. Favorites PDF Get Content & Permissions Free
Complications of Diagnostic Tests Following Lung Cancer Screening Brophy Marcus, Mary Brophy Marcus, Mary Less Oncology Times. 41(6):21-22, March 20, 2019. Favorites PDF Get Content & Permissions Free
Navigating a New Path to Test Peripheral Lung Nodules Holt, Chuck Holt, Chuck Less Oncology Times. 41(6):1-2, March 20, 2019. Favorites PDF Get Content & Permissions Free
Free Lung Cancer Screening Builds Valuable Relationships With Patients Less Oncology Times. 41(4):34, February 20, 2019. Favorites PDF Get Content & Permissions Free
Complication Rates & Costs of Lung Cancer Diagnostic Tests Less Oncology Times. 41(3):28, February 5, 2019. Favorites PDF Get Content & Permissions Free
OAK Trial Shows Fast Progression Is Not More Common With Atezolizumab Less Oncology Times. 41(2):36, January 20, 2019. Favorites PDF Get Content & Permissions Free
Second-Line Nivolumab Is Not Superior to Chemotherapy in SCLC Less Oncology Times. 41(2):21, January 20, 2019. Favorites PDF Get Content & Permissions Free
First-Line Immunotherapy Combination Fails to Improve OS in Lung Cancer Less Oncology Times. 41(2):20, January 20, 2019. Favorites PDF Get Content & Permissions Free
Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 40(22):34, November 20, 2018. Favorites PDF Get Content & Permissions Free
Detection of Early-Stage Lung Cancer When Surgical Cure Still Possible Less Oncology Times. 40(21):26, November 5, 2018. Favorites PDF Get Content & Permissions Free
Treatment Resistance in EGFR-Mutant NSCLC & Acquired RET Fusion Less Oncology Times. 40(20):50, October 20, 2018. Favorites PDF Get Content & Permissions Free
Promising Results for Entrectinib Against ROS1-Positive NSCLC Less Oncology Times. 40(20):45, October 20, 2018. Favorites PDF Get Content & Permissions Free
Brigatinib Becomes Potential First-Line Option for ALK-Positive NSCLC Less Oncology Times. 40(20):44, October 20, 2018. Favorites PDF Get Content & Permissions Free
LOXO-292 Durability Update in Patients With RET Fusion-Positive NSCLC Less Oncology Times. 40(20):43, October 20, 2018. Favorites PDF Get Content & Permissions Free
Poziotinib Sustains High Response Rates Against Lung Cancer Mutation Less Oncology Times. 40(19):22, October 5, 2018. Favorites PDF Get Content & Permissions Free
Promising Immunotherapies in Early-Stage Lung Cancer Less Oncology Times. 40(16):16, August 20, 2018. Favorites PDF Get Content & Permissions Free
Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers Less Oncology Times. 40(16):28, August 20, 2018. Favorites PDF Get Content & Permissions Free
Potential Value of Real-World Evidence in Lung Cancer Care Eastman, Peggy Eastman, Peggy Less Oncology Times. 40(16):1,7,13, August 20, 2018. Favorites PDF Get Content & Permissions Free
Genome-Wide Sequencing Detects Early Stage Lung Cancer From Blood Samples Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(14):31, July 20, 2018. Favorites PDF Get Content & Permissions Free
Adding Immunotherapy to Chemotherapy in Advanced Squamous Lung Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(14):29, July 20, 2018. Favorites PDF Get Content & Permissions Free
Pembrolizumab Monotherapy Extended Survival in Advanced Lung Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 40(13):36,55, July 5, 2018. Favorites PDF Get Content & Permissions Free
Upfront Genetic Testing of Non-Small Cell Lung Cancer Is Cost-Effective Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(13):34, July 5, 2018. Favorites PDF Get Content & Permissions Free
Registry Reveals Low Lung Cancer Screening of Smokers Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(13):33, July 5, 2018. Favorites PDF Get Content & Permissions Free
Lung Cancer: Geriatric Assessment Before Concurrent Chemo-Radiotherapy Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 40(12):39, June 20, 2018. Favorites PDF Get Content & Permissions Free
Handgrip Strength Predicts Survival in Elderly Patients With Lung Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 40(12):34, June 20, 2018. Favorites PDF Get Content & Permissions Free
Neoadjuvant Nivolumab in Patients With Resectable Non-Small Cell Lung Cancer Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(11):41-42, June 5, 2018. Favorites PDF Get Content & Permissions Free
Evaluating Nivolumab + Ipilimumab vs. Standard Chemo in NSCLC Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(11):38,40, June 5, 2018. Favorites PDF Get Content & Permissions Free
Treatment for ALK-Positive & ALK-Negative Inflammatory Myofibroblastic Tumors Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(11):35-36, June 5, 2018. Favorites PDF Get Content & Permissions Free
Evaluating Chemotherapy & Pembrolizumab in Metastatic NSCLC Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(11):33-34, June 5, 2018. Favorites PDF Get Content & Permissions Free
Longer Symptom Improvement in ALK-Positive Lung Cancer Less Oncology Times. 40(11):31, June 5, 2018. Favorites PDF Get Content & Permissions Free
Immunotherapy & Long-Term Survival for Lung Cancer Patients Less Oncology Times. 40(11):24, June 5, 2018. Favorites PDF Get Content & Permissions Free
Immunotherapy Shows Promise Among Lung Cancer Patients Nalley, Catlin Nalley, Catlin Less Oncology Times. 40(10):40-41, May 20, 2018. Favorites PDF Get Content & Permissions Free
New Immunotherapy for Lung Cancer Shows Promise of Success Less Oncology Times. 40(9):30, May 5, 2018. Favorites PDF Get Content & Permissions Free
Updated ASTRO Guideline for Palliative Lung Radiation Less Oncology Times. 40(9):27, May 5, 2018. Favorites PDF Get Content & Permissions Free
Crizotinib (Xalkori®) Skirvin, J. Andrew Skirvin, J. Andrew Less Oncology Times. 39(24):30, December 25, 2017. Favorites PDF Get Content & Permissions Free
Osimertinib Improves PFS in Asian EGFR-Mutated Lung Cancer Patients Less Oncology Times. 39(24):51, December 25, 2017. Favorites PDF Get Content & Permissions Free
Mutations in Cerebrospinal Fluid in Lung Cancer With Brain Metastases Less Oncology Times. 39(24):45, December 25, 2017. Favorites PDF Get Content & Permissions Free
Genetic Testing for EGFR Mutations in NSCLC Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 39(24):20,33, December 25, 2017. Favorites PDF Get Content & Permissions Free
